Cargando…
Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells
BACKGROUND: Understanding the signalling pathways involved in angiogenesis, and developing anti-angiogenic drugs are one of the major focuses on cancer research. Herein, we assessed the effect of CPTH6, a lysine acetyltransferase inhibitor and anti-tumoral compound, on angiogenesis-related propertie...
Autores principales: | Di Martile, Marta, Gabellini, Chiara, Desideri, Marianna, Matraxia, Marta, Farini, Valentina, Valentini, Elisabetta, Carradori, Simone, Ercolani, Cristiana, Buglioni, Simonetta, Secci, Daniela, Andreazzoli, Massimiliano, Del Bufalo, Donatella, Trisciuoglio, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273677/ https://www.ncbi.nlm.nih.gov/pubmed/32498717 http://dx.doi.org/10.1186/s13046-020-01604-z |
Ejemplares similares
-
Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
por: Di Martile, Marta, et al.
Publicado: (2016) -
BCL-X(L) overexpression promotes tumor progression-associated properties
por: Trisciuoglio, Daniela, et al.
Publicado: (2017) -
Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer
por: Trisciuoglio, Daniela, et al.
Publicado: (2018) -
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
por: Di Martile, Marta, et al.
Publicado: (2020) -
The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target
por: Di Martile, Marta, et al.
Publicado: (2016)